Literature DB >> 29066300

Upregulation of functional Kv11.1a isoform expression by modified U1 small nuclear RNA.

Qiuming Gong1, Matthew R Stump2, Zhengfeng Zhou3.   

Abstract

The KCNH2 or human ether-a go-go-related gene (hERG) encodes the Kv11.1 potassium channel that conducts the rapidly activating delayed rectifier potassium current in the heart. The expression of Kv11.1 C-terminal isoforms is directed by the alternative splicing and polyadenylation of intron 9. Splicing of intron 9 leads to the formation of a functional, full-length Kv11.1a isoform and polyadenylation of intron 9 results in the production of a non-functional, C-terminally truncated Kv11.1a-USO isoform. The relative expression of Kv11.1a and Kv11.1a-USO plays an important role in regulating Kv11.1 channel function. In the heart, only one-third of KCNH2 pre-mRNA is processed to Kv11.1a due to the weak 5' splice site of intron 9. We previously showed that the weak 5' splice site is caused by sequence deviation from the consensus, and that mutations toward the consensus sequence increased the efficiency of intron 9 splicing. It is well established that 5' splice sites are recognized by complementary base-paring with U1 small nuclear RNA (U1 snRNA). In this study, we modified the sequence of U1 snRNA to increase its complementarity to the 5' splice site of KCNH2 intron 9 and observed a significant increase in the efficiency of intron 9 splicing. RNase protection assay and western blot analysis showed that modified U1 snRNA increased the expression of the functional Kv11.1a isoform and concomitantly decreased the expression of the non-functional Kv11.1a-USO isoform. In patch-clamp experiments, modified U1 snRNA significantly increased Kv11.1 current. Our findings suggest that relative expression of Kv11.1 C-terminal isoforms can be regulated by modified U1 snRNA.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alternative polyadenylation; Arrhythmia; Long QT syndrome; Splicing; U1 snRNA; hERG

Mesh:

Substances:

Year:  2017        PMID: 29066300      PMCID: PMC5755592          DOI: 10.1016/j.gene.2017.10.063

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  24 in total

1.  Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature.

Authors:  Z Zhou; Q Gong; B Ye; Z Fan; J C Makielski; G A Robertson; C T January
Journal:  Biophys J       Date:  1998-01       Impact factor: 4.033

2.  Upregulation of functional Kv11.1 isoform expression by inhibition of intronic polyadenylation with antisense morpholino oligonucleotides.

Authors:  Qiuming Gong; Matthew R Stump; Zhengfeng Zhou
Journal:  J Mol Cell Cardiol       Date:  2014-08-14       Impact factor: 5.000

Review 3.  Role of ERG1 isoforms in modulation of ERG1 channel trafficking and function.

Authors:  Anders Peter Larsen
Journal:  Pflugers Arch       Date:  2010-06-24       Impact factor: 3.657

4.  A compensatory base change in U1 snRNA suppresses a 5' splice site mutation.

Authors:  Y Zhuang; A M Weiner
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

5.  Induction of antagonistic soluble decoy receptor tyrosine kinases by intronic polyA activation.

Authors:  Sandra Vorlová; Gina Rocco; Clare V Lefave; Francine M Jodelka; Ken Hess; Michelle L Hastings; Erik Henke; Luca Cartegni
Journal:  Mol Cell       Date:  2011-09-16       Impact factor: 17.970

6.  Two isoforms of the mouse ether-a-go-go-related gene coassemble to form channels with properties similar to the rapidly activating component of the cardiac delayed rectifier K+ current.

Authors:  B London; M C Trudeau; K P Newton; A K Beyer; N G Copeland; D J Gilbert; N A Jenkins; C A Satler; G A Robertson
Journal:  Circ Res       Date:  1997-11       Impact factor: 17.367

7.  Gene therapeutic approach using mutation-adapted U1 snRNA to correct a RPGR splice defect in patient-derived cells.

Authors:  Esther Glaus; Fabian Schmid; Romain Da Costa; Wolfgang Berger; John Neidhardt
Journal:  Mol Ther       Date:  2011-02-15       Impact factor: 11.454

8.  U1 snRNA-mediated gene therapeutic correction of splice defects caused by an exceptionally mild BBS mutation.

Authors:  Fabian Schmid; Esther Glaus; Daniel Barthelmes; Manfred Fliegauf; Harald Gaspar; Gudrun Nürnberg; Peter Nürnberg; Heymut Omran; Wolfgang Berger; John Neidhardt
Journal:  Hum Mutat       Date:  2011-07       Impact factor: 4.878

9.  A K+ channel splice variant common in human heart lacks a C-terminal domain required for expression of rapidly activating delayed rectifier current.

Authors:  S Kupershmidt; D J Snyders; A Raes; D M Roden
Journal:  J Biol Chem       Date:  1998-10-16       Impact factor: 5.157

10.  An engineered U1 small nuclear RNA rescues splicing defective coagulation F7 gene expression in mice.

Authors:  D Balestra; A Faella; P Margaritis; N Cavallari; F Pagani; F Bernardi; V R Arruda; M Pinotti
Journal:  J Thromb Haemost       Date:  2014-02       Impact factor: 5.824

View more
  3 in total

Review 1.  The Genetics and Epigenetics of Ventricular Arrhythmias in Patients Without Structural Heart Disease.

Authors:  Mengru Wang; Xin Tu
Journal:  Front Cardiovasc Med       Date:  2022-06-15

2.  Regulation of Kv11.1 potassium channel C-terminal isoform expression by the RNA-binding proteins HuR and HuD.

Authors:  Qiuming Gong; Matthew R Stump; Zhengfeng Zhou
Journal:  J Biol Chem       Date:  2018-10-29       Impact factor: 5.157

3.  Regulation of Kv11.1 Isoform Expression by Polyadenylate Binding Protein Nuclear 1.

Authors:  Matthew R Stump; Rachel T Nguyen; Rachel H Drgastin; Delaney Search; Qiuming Gong; Zhengfeng Zhou
Journal:  Int J Mol Sci       Date:  2021-01-16       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.